1. Home
  2. DXCM vs ASX Comparison

DXCM vs ASX Comparison

Compare DXCM & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • ASX
  • Stock Information
  • Founded
  • DXCM 1999
  • ASX 1984
  • Country
  • DXCM United States
  • ASX Taiwan
  • Employees
  • DXCM N/A
  • ASX N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • ASX Semiconductors
  • Sector
  • DXCM Health Care
  • ASX Technology
  • Exchange
  • DXCM Nasdaq
  • ASX Nasdaq
  • Market Cap
  • DXCM 28.0B
  • ASX 22.5B
  • IPO Year
  • DXCM 2005
  • ASX 1995
  • Fundamental
  • Price
  • DXCM $80.91
  • ASX $9.91
  • Analyst Decision
  • DXCM Buy
  • ASX Strong Buy
  • Analyst Count
  • DXCM 17
  • ASX 1
  • Target Price
  • DXCM $101.29
  • ASX N/A
  • AVG Volume (30 Days)
  • DXCM 4.0M
  • ASX 6.7M
  • Earning Date
  • DXCM 10-24-2024
  • ASX 10-31-2024
  • Dividend Yield
  • DXCM N/A
  • ASX 3.26%
  • EPS Growth
  • DXCM 83.21
  • ASX N/A
  • EPS
  • DXCM 1.67
  • ASX 0.23
  • Revenue
  • DXCM $3,954,000,000.00
  • ASX $18,693,593,707.00
  • Revenue This Year
  • DXCM $13.10
  • ASX $6.13
  • Revenue Next Year
  • DXCM $14.79
  • ASX $14.78
  • P/E Ratio
  • DXCM $48.52
  • ASX $20.15
  • Revenue Growth
  • DXCM 16.19
  • ASX N/A
  • 52 Week Low
  • DXCM $62.34
  • ASX $8.10
  • 52 Week High
  • DXCM $142.00
  • ASX $12.86
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 70.00
  • ASX 51.82
  • Support Level
  • DXCM $77.50
  • ASX $9.31
  • Resistance Level
  • DXCM $79.38
  • ASX $10.05
  • Average True Range (ATR)
  • DXCM 2.64
  • ASX 0.21
  • MACD
  • DXCM 0.57
  • ASX 0.03
  • Stochastic Oscillator
  • DXCM 97.86
  • ASX 80.41

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About ASX ASE Technology Holding Co. Ltd. (each representing Two)

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Electronic Manufacturing Services contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Share on Social Networks: